Ligand Pharmaceuticals, Inc. (LGND)
209.87
-22.34
(-9.62%)
USD |
NASDAQ |
May 07, 16:00
209.87
0.00 (0.00%)
After-Hours: 20:00
Ligand Pharmaceuticals Research and Development Expense (Annual) : 81.18M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| XOMA Royalty Corp. | 1.712M |
| Amicus Therapeutics, Inc. | 135.84M |
| Johnson & Johnson | 14.83B |
| ADMA Biologics, Inc. | 4.762M |
| Travere Therapeutics, Inc. | 206.01M |